FindTrial
Sign In

Biochemical estimation of urinary 5-HIAA & Serotonine in neuroendocrine tumors

5-Hydroxyindoleacetic acid and serotonin in 24 hours urine of patients with neuroendocrine tumors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2015/06/005882
Enrollment
200
Registered
2015-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients of benign and metastasis neuroendocrine tumors

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Having benign & malignant neuroendocrine tumors.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Try to identify and monitoring the origin of neuroendocrine tumors by biochemical tools.Timepoint: 1 Year—

Secondary

MeasureTime frame
Urine serotonin measurement as a new biochemical indicator which can distinguish the origin of neuroendocrine tumorsTimepoint: 1 year—

Countries

India

Contacts

Public ContactMeera S Ghadge

Tata Memorial Hospital

meeraghadge@gmail.com9821756723

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026